Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
3.83 USD
9.43%
Market Closed
Updated:
May 13, 2024
Adaptive Biotechnologies Corp
Total Liabilities
|
Adaptive Biotechnologies Corp
Total Liabilities Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Total Liabilities
$345.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Total Liabilities
$52B
|
CAGR 3-Years
15%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
|
|
Danaher Corp
NYSE:DHR
|
Total Liabilities
$30B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Total Liabilities
$3.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Total Liabilities
$4.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-1%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Total Liabilities
$20.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
19%
|
See Also
What is Adaptive Biotechnologies Corp's Total Liabilities?
Total Liabilities
345.4m
USD
345.4m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Total Liabilities amounts to 345.4m USD.
What is Adaptive Biotechnologies Corp's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
1%
1%
Over the last year, the Total Liabilities growth was -6%.
You don't have any saved screeners yet
